Home / Locations / Frankfurt
CMS in Frankfurt am Main

Frankfurt

Germany

The roots and earliest client relationships of our Frankfurt office date back to the early 1970s, and the firm has been a trusted adviser to businesses ever since. Today, CMS has a team of more than 75 lawyers based in the city’s Riverside Financial District, with the geographical proximity to Frankfurt’s banking and finance centre reflecting the strong position of our banking and finance practice, in particular when it comes to capital market law, asset management and structuring fund products.

Alongside our banking and finance work, our practice also includes private equity, commercial and corporate law, M&A, labour and employment, tax and antitrust law. We regularly advise clients on high-value real estate transactions and can also provide you with specialist insolvency law expertise.

Contact us to find out how you can benefit from our know-how in one of Europe’s major financial centres. Our legal experts and sector-specific teams look forward to working with you in Frankfurt!

more less

Directions

By plane

Frankfurt airport is approx. 12 kilometres from the CMS Frankfurt office which will take about 20 minutes by taxi.

By car

Visitors’ parking is available in our underground car park. Access to the car park is next to the main entrance off Neue Mainzer Straße.

By train

From Frankfurt main station it’s a twelve-minute walk to our office.

Alternatively, you can use public transport (U-Bahn):

From Frankfurt Hauptbahnhof (train station): Take the U5 (towards Preungesheim) or the U4 (towards Seckbacher Landstraße or Enkheim) and get off at Willy-Brandt-Platz. Follow the exit signs "Städtische Bühnen" / "Weißfrauenstraße" for Neue Mainzer Straße 2-4 (about 150 m).

From Hauptwache: Take the U1, U2 , U3 or U8 lines (towards Südbahnhof) and get off at Willy-Brandt-Platz. Follow the exit signs "Städtische Bühnen" / "Weißfrauenstraße" for Neue Mainzer Straße 2-4 (about 150 m).

more less

Location

CMS Hasche Sigle
Neue Mainzer Straße 2–4
60311 Frankfurt
Germany
Directions PDF Open Google Maps
April 2019
Not­ari­al ser­vices in Ber­lin, Frank­furt / Main and Stut­tgart

Feed

Show only
16/01/2020
CMS ad­vises Sig­na­ture Cap­it­al on ac­quis­i­tion of prop­erty...
21 Jan 20
In­tern­al in­vest­ig­a­tions in HR cases – best prac­tices
Em­ploy­ment we­bin­ar series
17 Jan 20
Who takes the lead? – The Ger­man Fed­er­al Su­preme Court provides guid­ance...
Ger­man Fed­er­al Su­preme Court, Or­der of 19 Septem­ber 2019, BGH I ZB 4/19 On 19 Septem­ber 2019, the Ger­man Fed­er­al Su­preme Court (BGH) is­sued a de­cision deal­ing with the in­ter­play between court pro­ceed­ings...
October 2019
New mat­ri­mo­ni­al prop­erty law: Need of ad­apt­a­tion and...
25 Feb 20
Top Tech­no­logy Pre­dic­tions 2020
Mo­bile World Con­gress Re­cep­tion
16 Jan 20
Ger­man Fed­er­al Su­preme Court grants dam­ages for breach of choice-of-court...
Ger­man Fed­er­al Su­preme Court, De­cision of 17 Oc­to­ber 2019 – III ZB 42/19 In a land­mark de­cision on 17 Oc­to­ber 2019, the Ger­man Fed­er­al Su­preme Court (BGH) de­cided for the first time that bring­ing a...
15/01/2020
CMS ad­vises mer­ger of ship­ping com­pan­ies Con­tain­er­ships...
15 Jan 20
Can newly dis­covered can­nabis com­pounds be pro­tec­ted by pat­ents?
A break­through dis­cov­ery has re­cently hit the news: tet­rahy­drocan­nabi­phorol (THCP) and can­na­bid­i­phorol (CB­DP), two new can­nabin­oid com­pounds, have been dis­covered in Can­nabis sativa and char­ac­ter­ised...
CMS Ex­pert Guide to La­bour Law in Cent­ral East­ern Europe
06 Jan 20
Land­mark cli­mate change judg­ment: Dutch gov­ern­ment again com­pre­hens­ively...
On 20 Decem­ber 2019, the highest court (Su­preme Court) in the Neth­er­lands dis­missed the Dutch Gov­ern­ment’s fi­nal ap­peal in the land­mark cli­mate change case, Ur­genda Found­a­tion v The Neth­er­lands. This...
10/12/2020
CMS ad­vises Tele­fón­ica Deutsch­land on con­clu­sion of...
23 Dec 19
So­cial Me­dia and mHealth Data EMA / HMA Re­port
New and in­nov­at­ive tech­no­lo­gies have led to a huge in­crease in data com­ing from sources that haven’t pre­vi­ously been used with­in the reg­u­lated medi­cines in­dustry. In re­cog­ni­tion of this ex­plo­sion of...